(Q67949628)
Statements
Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) (English)
J R Hardy
V J Harvey
J W Paxton
P Evans
S Smith
W Grove
A J Grillo-Lopez
1 November 1988